This article reviews current strategies used in the treatment of uncomplica
ted forms of malaria due to Plasmodium falciparum. A comprehensive search i
n selected medical databases (Medline, Pascal, and Embase) was performed on
publications containing specific key words (P. falciparum, uncomplicated m
alaria, halofantrine, mefloquine, quinine, amodiaquine, sulfadoxine, pyrime
thamine, and atovaquone). Only relevant review articles, randomized control
led therapeutic trials, and open trials written in English or French were s
elected. Most publications dealt with drug therapy against chemoresistant s
trains of P. falciparum in immune and semi-immune individuals, while some d
iscussed antimalarial treatment in nonimmune subjects. Search results indic
ated that first-line antimalarial agents included halofantrine, mefloquine,
and quinine, alone or in combination with tetracycline antibiotics. Criter
ia for choosing a particular drug included toxicity, contraindications, and
geographical origin of the patient. The presence of any single severe clin
ical or biological symptom made hospitalization mandatory. (C) 1999 Edition
s scientifiques et medicales Elsevier SAS.